EGFR and non-small cell lung carcinoma: Takahama et al. [39] evaluated liquid biopsy assays for detection of TKI‐sensitizing and T790M mutations of EGFR by ddPCR in EGFR mutation positive NSCLC patients with acquired EGFR‐TKI resistance.